Clinical Trial

Safety and Efficacy of Edaravone Dexborneol for Acute Ischemic Stroke

Not Yet Recruiting Phase 4
View on ClinicalTrials.gov →
Summary
The purpose of this study is to determine the efficacy and safety of edaravone dexborneol in treating acute ischemic stroke.
Trial Details
NCT Number NCT06645522
Lead Sponsor Yi Yang
Conditions Acute Ischemic Stroke
Enrollment 1,200 participants
Start Date 2024-10-30
Primary Completion 2026-10-30 (estimated)
Study Completion 2027-01-30 (estimated)
Updated on ClinicalTrials.gov 2024-10-17